Literature DB >> 22357455

Current understanding of rheumatoid arthritis therapy.

Inés Colmegna1, Brent R Ohata, Henri A Menard.   

Abstract

Progress in understanding the cellular and molecular mechanisms of rheumatoid arthritis (RA), together with the availability of new therapies, has changed the way we think about RA. The paradigm shift in RA therapy has been from controlling symptoms to controlling the disease process with the abrogation of inflammation. Challenges that are still unresolved include the issues in disease prevention, treatment specificity to restore tolerance, approaches to facilitate tissue repair, and treatment optimization to fit the individual patient's disease phenotype and comorbidity context. This review summarizes the pathogenesis-related rationales for the current therapeutic strategies in RA and for emerging therapies and potential approaches to restoring immune tolerance in RA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357455     DOI: 10.1038/clpt.2011.325

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  38 in total

Review 1.  Clinical trials of integrative medicine for rheumatoid arthritis: Issues and recommendations.

Authors:  Chi Zhang; Miao Jiang; Xiao-Juan He; Ai-Ping Lu
Journal:  Chin J Integr Med       Date:  2015-06-11       Impact factor: 1.978

2.  Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events.

Authors:  Diogo Mendes; Carlos Alves; Francisco Batel Marques
Journal:  Clin Rheumatol       Date:  2013-04-21       Impact factor: 2.980

3.  Inhibition of spinal p38 MAPK prevents articular neutrophil infiltration in experimental arthritis via sympathetic activation.

Authors:  Alexandre Kanashiro; Marcelo Franchin; Gabriel Shimizu Bassi; Dênis Augusto Reis Santana; Thiago Mattar Cunha; Fernando Queiróz Cunha; Luis Ulloa; Gerson Jonathan Rodrigues
Journal:  Fundam Clin Pharmacol       Date:  2017-12-22       Impact factor: 2.748

Review 4.  Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis.

Authors:  Kenneth S Rosenthal; Katalin Mikecz; Harold L Steiner; Tibor T Glant; Alison Finnegan; Roy E Carambula; Daniel H Zimmerman
Journal:  Expert Rev Vaccines       Date:  2015-03-18       Impact factor: 5.217

Review 5.  Vitamin D Deficiency and Rheumatoid Arthritis.

Authors:  Larissa Lumi Watanabe Ishikawa; Priscila Maria Colavite; Thais Fernanda de Campos Fraga-Silva; Luiza Ayumi Nishiyama Mimura; Thais Graziela Donegá França; Sofia Fernanda Gonçalves Zorzella-Pezavento; Fernanda Chiuso-Minicucci; Larissa Doddi Marcolino; Marcimara Penitenti; Maura Rosane Valerio Ikoma; Alexandrina Sartori
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

6.  Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients.

Authors:  Niveditha Muralidharan; Reena Gulati; Durga Prasanna Misra; Vir S Negi
Journal:  Clin Exp Med       Date:  2017-08-18       Impact factor: 3.984

Review 7.  Foot tendinopathies in rheumatic diseases: etiopathogenesis, clinical manifestations and therapeutic options.

Authors:  A Frizziero; V Bonsangue; M Trevisan; P R J Ames; S Masiero
Journal:  Clin Rheumatol       Date:  2012-12-30       Impact factor: 2.980

8.  Pharmacokinetics, pharmacodynamics and toxicities of methotrexate in healthy and collagen-induced arthritic rats.

Authors:  Dong-Yang Liu; Hoi-Kei Lon; Yan-Lin Wang; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2013-04-07       Impact factor: 1.627

9.  Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach.

Authors:  Hoi-Kei Lon; Dongyang Liu; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12       Impact factor: 2.745

10.  Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study.

Authors:  Nathalie Berghen; Laure-Anne Teuwen; Rene Westhovens; Patrick Verschueren
Journal:  Clin Rheumatol       Date:  2015-07-30       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.